Vimarsana
Biggest News Aggregation in the World

Page 7 - Protein Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Protein Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Protein Sciences Today - Breaking & Trending Today

As obesity drugs soar, Mass. biotechs seek a slice of the market - Vimarsana News

As obesity drugs soar, Mass. biotechs seek a slice of the market

Several biotechs in Mass. are seeking to elbow their way into the lucrative market, which is currently dominated by Denmark’s Novo Nordisk, which makes Wegovy and Ozempic, and Eli Lilly, which produces Mounjaro.

3 Healthcare Stocks to Keep an Eye On | The Motley Fool - Vimarsana News

3 Healthcare Stocks to Keep an Eye On | The Motley Fool

These three lesser-known healthcare companies have strong growth potential.

Source: fool.com
Head to Head Review: Immunocore (NASDAQ:IMCR) versus Bio-Techne (NASDAQ:TECH) - Vimarsana News

Head to Head Review: Immunocore (NASDAQ:IMCR) versus Bio-Techne (NASDAQ:TECH)

Immunocore (NASDAQ:IMCR – Get Free Report) and Bio-Techne (NASDAQ:TECH – Get Free Report) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, risk, valuation, profitability, institutional ownership and earnings. Profitability This table compares Immunocore and Bio-Techne’s net margins, return […]

BIO-TECHNE INTEGRATES ITS MAURICE SYSTEM WITH THE THERMO SCIENTIFIC CHROMELEON CHROMATOGRAPHY DATA SYSTEM - Vimarsana News

BIO-TECHNE INTEGRATES ITS MAURICE SYSTEM WITH THE THERMO SCIENTIFIC CHROMELEON CHROMATOGRAPHY DATA SYSTEM

/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) is pleased to launch the new Maurice Chromeleon Driver Kit, which enables control of its Maurice™...

Bio-Techne Co. (NASDAQ:TECH) Receives $101.78 Average Price Target from Analysts - Vimarsana News

Bio-Techne Co. (NASDAQ:TECH) Receives $101.78 Average Price Target from Analysts

Bio-Techne Co. (NASDAQ:TECH – Get Free Report) has received an average rating of “Moderate Buy” from the nine research firms that are presently covering the firm, Marketbeat reports. Two analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 1 year price target among […]